Expressions of PD‐L1 and PD‐L2 were predominantly in tumor‐infiltrating lymphocytes and showed significant negative correlations with CD4+ or CD8+ infiltrates, respectively (Figure 4B,C). This evidence concerns the gene CD8A and neoplasm.